Bioventus Inc reports results for the quarter ended in June - Earnings Summary

Bioventus

06/08/2024 15:23

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of
19 cents​​ per share for the quarter ended in June, higher than
the same quarter last year, when the company reported EPS of 14
cents.  The mean expectation of three analysts for the quarter
was for earnings of 7 cents per share. Wall Street expected
results to range from 6 cents to 7 cents per share.
    * Revenue rose 10.3% to $151.22 million from a year ago;
analysts
expected $137.59 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 37
cents​.
    * The company reported a quarterly loss of $23.99 million.
    * Bioventus Inc shares had risen by 8.9% this quarter and
gained 18.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Bioventus Inc is
$8.50 
This summary was machine generated from LSEG data August 6 at
02:23 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.07           0.19           Beat
 Mar. 31 2024      -0.07          0.07           Beat
 Dec. 31 2023      0.02           0.07           Beat
 Sep. 30 2023      -0.02          0.05           Beat